Prothena Corporation plc (PRTA) - Biji pasar

Prothena Corporation (PRTA) develops targeted antibodies to combat protein misfolding disorders in the body. The company leverages advanced protein mapping techniques to overcome Alzheimer's and Parkinson's pathologies. The current metric stands at 0.41. High scientific authority and the support of major partners validate the platform's potential, as clearly demonstrated by the asset price chart below.

prothena.com - Kapitalisasi pasar PRTA (periode 04.07.2022 - 22.10.2026)

PRTA (Prothena Corporation PLC): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Prothena Corporation (PRTA):

Bagan rega Prothena|PRTA - Konsensus nilai wajar|Biji pasar Prothena Biosciences

Analisis fundamental perusahaan:PRTA (Prothena Corporation)

Sampel barang Prothena Biosciences

Fundamental asset screening begins by determining the total business value, a metric calculated as the product of the current share price and the number of outstanding securities. By analyzing the issuer's market value chart, an investor assesses the company's actual stability, separating speculation from growth. For Prothena Corporation (PRTA), this metric reflects market expectations for the therapy of neurodegenerative pathologies. Market capitalization will increase following the commercial launch of drugs targeting Alzheimer's disease.

Pesaing wigati

Nilai pasar Biogen BIIB|Nilai pasar NBIX|RGC: Biji pasar|Axsome Corp - Nilai pasar|ACAD: Kapitalisasi pasar|xenon-pharma.com (XENE) - Kapitalisasi pasar|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|Nilai pasar CeriBell, Inc.|Alector Therapeutics - Biji pasar|Nilai pasar Annexon (ANNX)|OMER (omeros.com) - Nilai pasar|Nilai pasar Neurogene Corp NGNE|AC Immune Inc (ACIU) - Nilai pasar|VYGR: Biji pasar|neumoratx.com - Nilai pasar|SCLX: Kapitalisasi pasar|Tevogen Bio Holdings Inc. - Nilai pasar|ACOG (Alpha Cognition Inc) - Kapitalisasi pasar|Nilai pasar cogrx.com CGTX|Nilai pasar Inhibikase Therapeutics (IKT)|cassavasciences.com - Kapitalisasi pasar|Kapitalisasi pasar ASRT (Assertio)|Kapitalisasi pasar Coya Therapeutics Inc COYA|VTGN: Biji pasar|Nilai pasar OVID (Ovid Therapeutics Inc.)|ABOS: Kapitalisasi pasar|Biji pasar cervomed.com|Nilai pasar Alterity Therapeutics Ltd.|Nilai pasar Clene Nanomedicine CLNN|Nilai pasar PepGen Inc. (PEPG)|JUNS (jupiterneurosciences.com) - Nilai pasar|Nilai pasar Relmada Therapeutics RLMD|ANVS (annovisbio.com) - Biji pasar|GRCE - Nilai pasar|Nilai pasar Firefly Neuroscience, Inc.|anewmeds.com (KLTO) - Nilai pasar|NeuroSense Therapeutics Ltd. - Nilai pasar|RVPH (Reviva Pharmaceuticals) - Kapitalisasi pasar|Kapitalisasi pasar MetaVia, Inc.|Biji pasar NRXS (NeurAxis)|Nilai pasar HSDT|Kapitalisasi pasar PASG (Passage Bio)|Kapitalisasi pasar Neuphoria Therapeutics, Inc. (NEUP)|NERV - Nilai pasar|Nilai pasar athira.com|Addex Therapeutics Ltd (ADXN) - Nilai pasar|Kapitalisasi pasar ALZN|Nilai pasar Cyclerion Therapeutics Inc.|Protagenic - Biji pasar|Nilai pasar Pasithea Therapeutics (KTTA)|CRGT (cortigent.com) - Nilai pasar|Avenue Therapeutics, Inc. - Biji pasar|Nilai pasar BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc - Kapitalisasi pasar|CHRO - Kapitalisasi pasar|eliemtx.com (ELYM) - Nilai pasar|Kapitalisasi pasar ITCI|LBPH (Longboard Pharmaceuticals, Inc.) - Kapitalisasi pasar|Nilai pasar Marinus Pharmaceuticals Inc MRNS|Biji pasar NKGN (NKGen)|Kapitalisasi pasar NeuroBo Pharma (NRBO)|Nilai pasar Sage Therapeutics, Inc. SAGE|Nilai pasar SNPX|TRVN - Nilai pasar|Nilai pasar Vigil Neuroscience|Anew Medical, Inc. (WENA) - Nilai pasar|Biji pasar CERE (Cerevel Corp)